Overview

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

Status:
Completed

Trial end date:
2005-01-01

Target enrollment:

Participant gender:

Summary

A STUDY ON WHETHER AN ANTIHYPERTENSIVE MEDICATION PREVENTS DAMAGE TO WALLS OF VEINS IN FEMALE PATIENTS WITH THE METABOLIC SYNDROME (OVERWEIGHT AND OTHER DISORDERS).

Phase:

Phase 4

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine
Valsartan